Rayno Life Science Portfolio Update: Biotechs beat the Market
As of the end of Q3, 2010 has been a very good year for biotechnology stocks beating both the S&P (up 2.9% YTD) and the NASDAQ (up 4.9% YTD). However the QQQQ was up 7.75% YTD. The NYSE Arca Biotech Index is up 23.5% YTD and the First Trust Amex Biotech ETF (FBT) is up 22% YTD. Other drug...
Stealth Stock Rally Catches Bears off Guard:Don’t Fight the Tape
Biotech stocks rallied with the general market today with many large caps beating the QQQQ which is up about 1.85% as of midday trading. Within the Rayno Life Science Portfolio today's winners were: Large Caps-Biogen (BIIB) up 2.4%,Cephalon(CEPH) up 2.25%, Gilead (GILD) up 2.25%; Small and Mid...
Rodman&Renshaw Part 2:Rosetta Genomics(ROSG)and Response Genetics(RGDX)
Within the "diagnostics and tools" track at the Rodman and Renshaw Conference here are two interesting genomics companies that presented. Rosetta Genomics Ltd. (ROSG, $1.25) ,Market Cap $21M, Sh.Out. 16.5M Rosetta is an Israeli Company focused in development of microRNA-based diagnostics...
Rodman&Renshaw Notes Part 2: Sequenom (SQNM)
Sequenom (SQNM) $7, Market Cap $529M, 76M Sh. Outstanding Sequenom presented a financial update and their plans for their T21 trisomy 21 noninvasive pre-natal test for fetal gene and chromosomal abnormalities. The Company plans to launch a CLIA LDT (lab developed test) by Q4 2011 and submit a...
Sierra SnowBlog 2010 La Nina Pattern Next 3 Months: Cold for Northern U.S.
A weather pundit came on CNBC today reiterating La Nina and it impact on energy markets beginning in November. He is forecasting cold weather for the Northern tier in the U.S. (see below).
Watch Nat Gas come off its lows to low $4 range, now trading at $3.935.
Also The Rayno Report has a ski clip and a story from the latest Powder magazine on boutique ski gear.
Climate Prediction Center: ENSO Diagnostic Discussion
The Rayno Report | Ski Revolution!